Categorie
algemeen
300 middelen · sorteerbaar op meldingen, ROR of % ernstig.
300 van 300 getoond
| Product ↓ | Meldingen | % ernstig | Top signaal | ROR | Type |
|---|---|---|---|---|---|
zolpidem tartrate — | 132.956 | 69.3% | voltooide zelfmoord | 8.5 | drug |
x-ray — | 160.318 | 1.8% | — | — | device |
wearable cardioverter defibrillator — | 144.009 | 27.1% | — | — | device |
warfarin — | 126.794 | 79.5% | verhoogde INR | 100.9 | drug |
vitamin — | 120.098 | 59.0% | infuusgerelateerde reactie | 8.6 | drug |
ventilator, non-continuous (respirator) — | 273.528 | 20.7% | — | — | device |
ventilator, non-continuous — | 276.461 | 20.8% | — | — | device |
ventilator, continuous, facility use — | 124.158 | 6.3% | — | — | device |
ventilator, continuous, facility — | 129.333 | 6.3% | — | — | device |
ventilator, continuous — | 190.641 | 5.6% | — | — | device |
ventilator — | 517.948 | 14.6% | — | — | device |
venlafaxine hydrochloride — | 129.795 | 74.2% | serotoninesyndroom | 24.2 | drug |
venlafaxine — | 129.795 | 74.2% | serotoninesyndroom | 24.2 | drug |
valve — | 180.969 | 83.5% | — | — | device |
valsartan — | 242.787 | 65.0% | lage bloeddruk | 7.2 | drug |
ustekinumab — | 100.563 | 59.1% | anti-cyclisch citrulline peptide antistof positief | 220.1 | drug |
unvented volume infusion set with "y" sites — | 25.000.507 | 0.1% | — | — | device |
treprostinil — | 121.655 | 57.6% | pijn op de infusieplaats | 144.1 | drug |
topiramate — | 97.078 | 65.4% | Epilepsie | 13.4 | drug |
tofacitinib — | 185.980 | 48.6% | handmisvorming | 149.2 | drug |
tocilizumab — | 112.048 | 76.6% | anti-cyclisch citrulline peptide antistof positief | 1109.5 | drug |
tiotropium bromide — | 150.254 | 50.2% | verkeerde toedieningsroute van medicijn | 297.6 | drug |
teriparatide — | 111.637 | 37.1% | verhoogd calcium in bloed | 58.0 | drug |
tadalafil — | 98.103 | 62.5% | Pulmonale arteriële hypertensie | 53.3 | drug |
tacrolimus extended-release capsules — | 120.821 | 90.5% | polyomavirus-geassocieerde nefropathie | 465.4 | drug |
tacrolimus — | 152.389 | 89.9% | polyomavirus-geassocieerde nefropathie | 498.4 | drug |
system, peritoneal, automatic delivery — | 151.392 | 12.9% | — | — | device |
suture — | 190.872 | 47.8% | — | — | device |
stimulator, spinal-cord, totally implanted for pain relief — | 127.323 | 64.4% | — | — | device |
stimulator, spinal-cord, totally implanted for — | 172.949 | 55.4% | — | — | device |
sterile disposable 1/4 x 1/4 x 1/4 "y" connector — | 25.000.665 | 0.4% | — | — | device |
sterile disposable "x" "x" "y" connector — | 25.001.792 | 0.4% | — | — | device |
stent — | 201.113 | 54.7% | — | — | device |
staple, implantable — | 148.798 | 15.4% | — | — | device |
spironolactone — | 137.410 | 78.5% | hyperkaliëmie | 26.3 | drug |
sodium chloride — | 264.849 | 82.0% | peritonitis | 19.4 | drug |
simvastatin — | 261.343 | 72.2% | rabdomyolyse | 13.0 | drug |
sildenafil citrate — | 125.270 | 66.5% | toegenomen erectie | 434.4 | drug |
sildenafil — | 125.271 | 66.5% | toegenomen erectie | 434.4 | drug |
set, administration, intravascular — | 112.501 | 16.4% | — | — | device |
sertraline hydrochloride — | 116.450 | 63.7% | suïcidale gedachten | 5.7 | drug |
sertraline — | 214.801 | 71.6% | poging tot zelfdoding | 6.0 | drug |
sensor, glucose, invasive — | 115.806 | 1.4% | — | — | device |
secukinumab — | 158.767 | 39.8% | psoriatische artropathie | 47.1 | drug |
screw — | 147.842 | 79.9% | — | — | device |
sacubitril and valsartan — | 114.605 | 51.0% | Keelschrapen | 137.4 | drug |
rosuvastatin — | 223.851 | 68.3% | rabdomyolyse | 10.3 | drug |
rivaroxaban — | 205.037 | 83.9% | inwendige bloeding | 48.6 | drug |
rituximab — | 215.364 | 88.7% | pemphigus | 325.9 | drug |
risperidone — | 131.271 | 66.3% | Gynaecomastie | 755.0 | drug |
ranitidine — | 230.503 | 93.3% | Darmkanker | 73.6 | drug |
ramipril — | 121.234 | 93.4% | pemphigus | 47.4 | drug |
quetiapine — | 188.609 | 78.9% | diabetes type 2 | 23.9 | drug |
pump, infusion, insulin, to be used with invasive glucose sensor — | 415.417 | 8.0% | — | — | device |
pump, infusion, insulin, to be used with invasive — | 416.187 | 8.0% | — | — | device |
pump, infusion, insulin — | 596.309 | 9.1% | — | — | device |
pump, infusion — | 2.290.658 | 5.6% | — | — | device |
pump set with in line "y" adapter and spike — | 25.000.438 | 0.0% | — | — | device |
pump — | 4.522.200 | 10.3% | — | — | device |
pulse generator — | 254.361 | 55.6% | — | — | device |
prosthesis, breast, noninflatable, internal, silicone gel-filled — | 193.293 | 98.9% | — | — | device |
prosthesis, breast, noninflatable, internal, silicone — | 193.373 | 98.9% | — | — | device |
prosthesis, breast, inflatable, internal, saline — | 103.014 | 99.3% | — | — | device |
prosthesis, breast — | 297.602 | 99.0% | — | — | device |
pregabalin — | 267.198 | 66.6% | Ontwenningssyndroom | 9.2 | drug |
prednisone — | 491.157 | 78.5% | systemische lupus erythematosus | 20.1 | drug |
prednisolone oral solution — | 176.279 | 95.5% | Cytomegalovirusinfectie | 21.6 | drug |
prednisolone oral — | 176.280 | 95.5% | Cytomegalovirusinfectie | 21.6 | drug |
prednisolone — | 188.016 | 93.2% | Cytomegalovirusinfectie | 20.7 | drug |
potassium chloride — | 118.686 | 72.2% | Hypokaliëmie | 9.1 | drug |
pomalidomide — | 100.554 | 61.3% | multipel myeloom | 57.4 | drug |
polyethylene glycol 3350 — | 98.501 | 41.6% | verkeerde duur van toediening product | 28.2 | drug |
polyethylene glycol — | 123.342 | 47.0% | verkeerde duur van toediening product | 22.5 | drug |
phenylephrine hydrochloride — | 165.690 | 59.0% | infuusgerelateerde reactie | 11.9 | drug |
phenylephrine — | 217.644 | 56.7% | infuusgerelateerde reactie | 9.2 | drug |
permanent pacemaker electrode — | 247.451 | 51.5% | — | — | device |
pembrolizumab — | 100.432 | 87.3% | bijnierinsufficiëntie | 31.7 | drug |
pegfilgrastim — | 99.745 | 29.5% | probleem met hechting van hulpmiddel | 847.8 | drug |
pantoprazole sodium — | 144.620 | 78.0% | ernstige nierziekte | 105.7 | drug |
pantoprazole — | 323.510 | 81.3% | ernstige nierziekte | 61.2 | drug |
pain reliever — | 247.094 | 87.3% | infuusgerelateerde reactie | 17.5 | drug |
paclitaxel — | 95.870 | 96.3% | onderdrukking van beenmergactiviteit | 25.6 | drug |
pacemaker — | 713.129 | 45.7% | — | — | device |
oxycodone hydrochloride and acetaminophen — | 97.801 | 82.1% | afhankelijkheid | 133.7 | drug |
oxycodone hydrochloride — | 281.587 | 86.9% | medicijnverslaving | 194.1 | drug |
oxycodone — | 376.208 | 84.2% | medicijnverslaving | 131.2 | drug |
ondansetron tablets — | 105.951 | 80.8% | koortsige neutropenie | 15.3 | drug |
ondansetron hydrochloride — | 118.451 | 79.6% | koortsige neutropenie | 14.2 | drug |
ondansetron — | 118.456 | 79.6% | koortsige neutropenie | 14.2 | drug |
omeprazole magnesium — | 438.661 | 72.0% | ernstige nierziekte | 65.4 | drug |
omeprazole — | 442.282 | 71.8% | ernstige nierziekte | 65.1 | drug |
olanzapine — | 107.378 | 85.3% | neuroleptisch maligne syndroom | 57.7 | drug |
non-continuous (respirator) — | 273.623 | 20.7% | — | — | device |
natalizumab — | 180.199 | 31.2% | Algemeen symptoom | 47.9 | drug |
naproxen sodium — | 162.972 | 58.3% | synovitis | 37.6 | drug |
naproxen — | 162.981 | 58.3% | synovitis | 37.6 | drug |
mycophenolate mofetil hydrochloride — | 131.742 | 91.3% | transplantaatafwijzing | 171.7 | drug |
mycophenolate mofetil — | 131.745 | 91.3% | transplantaatafwijzing | 171.7 | drug |
morphine sulfate — | 119.783 | 85.6% | medicijnverslaving | 59.6 | drug |
morphine — | 190.113 | 86.1% | medicijnverslaving | 34.4 | drug |
montelukast sodium — | 118.894 | 60.7% | obstructieve luchtwegaandoening | 48.4 | drug |
montelukast — | 171.338 | 62.5% | astma | 27.1 | drug |
monitor — | 2.392.240 | 1.7% | — | — | device |
minoxidil foam 5% (womens) — | 3.436.075 | 75.5% | koortsige neutropenie | 8.6 | drug |
metoprolol tartrate — | 268.317 | 70.6% | atriumfibrilleren | 6.5 | drug |
metoprolol — | 347.924 | 68.7% | atriumfibrilleren | 6.3 | drug |
methylprednisolone — | 167.055 | 88.8% | infuusgerelateerde reactie | 15.8 | drug |
methotrexate sodium — | 478.279 | 73.3% | synovitis | 137.6 | drug |
methotrexate — | 484.893 | 72.6% | synovitis | 135.8 | drug |
metformin er 750 mg — | 294.217 | 67.9% | melkzuurvergiftiging | 47.4 | drug |
metformin er 500 mg — | 294.217 | 67.9% | melkzuurvergiftiging | 47.4 | drug |
metformin — | 433.187 | 66.8% | melkzuurvergiftiging | 75.1 | drug |
mesh, surgical — | 125.850 | 97.0% | — | — | device |
mesh — | 208.370 | 96.5% | — | — | device |
mds — | 129.235 | 2.3% | — | — | device |
magnesium — | 813.618 | 70.5% | ernstige nierziekte | 49.6 | drug |
losartan — | 206.980 | 63.8% | chronische nierziekte | 6.6 | drug |
lorazepam — | 176.559 | 76.9% | voltooide zelfmoord | 5.3 | drug |
loratadine — | 113.035 | 44.8% | extra dosis toegediend | 9.0 | drug |
lisinopril — | 310.213 | 61.0% | angio-oedeem | 12.7 | drug |
levothyroxine sodium anhydrous — | 97.348 | 69.8% | algemene verslechtering lichamelijke gezondheid | 4.4 | drug |
levothyroxine sodium — | 308.680 | 60.2% | Hartkloppingen | 3.7 | drug |
levonorgestrel — | 205.479 | 32.8% | spiraaltje uitgestoten | 11448.8 | drug |
levetiracetam — | 130.496 | 82.8% | Resistentie tegen meerdere geneesmiddelen | 146.4 | drug |
lenalidomide — | 414.396 | 64.0% | multipel myeloom | 40.2 | drug |
leflunomide — | 102.951 | 82.4% | anti-cyclisch citrulline peptide antistof positief | 1455.6 | drug |
lead — | 466.420 | 70.6% | — | — | device |
laryngotracheal cannula z vial inj + lidocaian 4% — | 1.222.352 | 0.0% | — | — | device |
lansoprazole — | 175.073 | 87.3% | ernstige nierziekte | 143.9 | drug |
lamotrigine — | 129.256 | 71.8% | Syndroom van Stevens-Johnson | 21.5 | drug |
knee — | 205.004 | 78.6% | — | — | device |
kit — | 360.069 | 9.8% | — | — | device |
iv catheter with "y" connector — | 25.000.665 | 0.4% | — | — | device |
intraocular lens — | 113.412 | 55.7% | — | — | device |
interferon beta-1a — | 191.751 | 53.1% | terugval multiple sclerose | 34.7 | drug |
insulin pump — | 171.535 | 22.8% | — | — | device |
insulin lispro — | 137.507 | 46.0% | verhoogde bloedglucose | 54.5 | drug |
insulin infusion pump / sensor augmented — | 315.367 | 24.4% | — | — | device |
insulin infusion pump — | 1.112.476 | 15.5% | — | — | device |
insulin glargine — | 243.678 | 51.6% | verhoogde bloedglucose | 26.1 | drug |
insulin — | 492.190 | 55.0% | verhoogde bloedglucose | 42.8 | drug |
instrument — | 341.890 | 7.8% | — | — | device |
infusion pump — | 1.968.975 | 13.1% | — | — | device |
infliximab — | 240.611 | 87.5% | pemphigus | 228.2 | drug |
implantable lead — | 123.714 | 69.9% | — | — | device |
implantable cardioverter defibrillator — | 269.031 | 55.9% | — | — | device |
implant, endosseous, root-form — | 372.575 | 99.8% | — | — | device |
implant — | 3.932.418 | 97.9% | — | — | device |
ibuprofen tablets usp, 200mg — | 195.040 | 72.9% | chronische nierziekte | 6.6 | drug |
ibuprofen tablet, film coated — | 195.036 | 72.9% | chronische nierziekte | 6.6 | drug |
ibuprofen oral — | 195.098 | 72.9% | chronische nierziekte | 6.6 | drug |
ibuprofen capsules 200 mg — | 195.145 | 72.9% | chronische nierziekte | 6.6 | drug |
ibuprofen capsule — | 198.873 | 72.2% | chronische nierziekte | 6.5 | drug |
ibuprofen 200mg — | 195.216 | 72.9% | Infectie van de lagere luchtwegen | 10.3 | drug |
ibuprofen 200 mg — | 195.158 | 72.9% | chronische nierziekte | 6.6 | drug |
ibuprofen — | 279.647 | 63.0% | gewrichtszwelling | 4.7 | drug |
ibupfrofen — | 195.038 | 72.9% | chronische nierziekte | 6.6 | drug |
hydroxychloroquine — | 149.345 | 78.0% | pemphigus | 408.7 | drug |
hydrocortisone — | 121.305 | 79.3% | synovitis | 50.7 | drug |
hydrocodone bitartrate — | 95.444 | 86.2% | Leerstoornis | 194.1 | drug |
hydrochlorothiazide — | 206.985 | 67.4% | Hyponatriëmie | 7.2 | drug |
huber needle w/winged ext set, 20g, 1", 8", y-site — | 997.066 | 0.0% | — | — | device |
hip — | 358.427 | 78.4% | — | — | device |
hi-flo "y" type blood pump set — | 25.000.438 | 0.0% | — | — | device |
head — | 98.806 | 63.4% | — | — | device |
guaifenesin — | 199.480 | 55.5% | infuusgerelateerde reactie | 8.7 | drug |
glucose sensor — | 415.717 | 8.1% | — | — | device |
glucose monitoring system — | 514.797 | 15.7% | — | — | device |
glucose monitoring sys/kit — | 295.057 | 8.8% | — | — | device |
glucose monitoring — | 903.717 | 12.9% | — | — | device |
glucose monitor — | 2.330.505 | 1.4% | — | — | device |
generator — | 331.466 | 49.6% | — | — | device |
gabapentin — | 359.779 | 63.3% | Medicijn niet effectief voor goedgekeurde indicatie | 7.4 | drug |
furosemide — | 393.086 | 81.3% | hartfalen met longoedeem | 9.3 | drug |
formoterol fumarate dihydrate — | 114.158 | 57.5% | obstructieve luchtwegaandoening | 49.3 | drug |
formoterol fumarate — | 125.520 | 56.1% | astma | 27.1 | drug |
folic acid — | 246.828 | 74.1% | pemphigus | 252.1 | drug |
fluticasone propionate and salmeterol — | 99.522 | 50.6% | astma | 23.2 | drug |
fluticasone propionate — | 189.078 | 49.1% | astma | 15.0 | drug |
fluoxetine hydrochloride — | 124.895 | 71.6% | serotoninesyndroom | 23.5 | drug |
fluoxetine — | 129.920 | 71.4% | serotoninesyndroom | 23.3 | drug |
fluoroscopic x-ray — | 143.731 | 0.7% | — | — | device |
flash glucose monitoring system — | 265.623 | 19.9% | — | — | device |
fentanyl — | 113.392 | 85.5% | medicijnmisbruik | 35.4 | drug |
femoral — | 138.549 | 87.0% | — | — | device |
famotidine — | 115.334 | 63.6% | ernstige nierziekte | 22.8 | drug |
evolocumab — | 157.026 | 15.6% | Moeilijk te gebruiken hulpmiddel | 166.1 | drug |
etanercept — | 592.886 | 36.0% | synovitis | 58.4 | drug |
estradiol — | 190.011 | 50.9% | chronische cholecystitis | 568.3 | drug |
esomeprazole magnesium — | 230.681 | 71.5% | ernstige nierziekte | 120.7 | drug |
esomeprazole — | 233.118 | 71.8% | ernstige nierziekte | 119.4 | drug |
escitalopram — | 136.935 | 67.2% | poging tot zelfdoding | 6.3 | drug |
ergocalciferol — | 374.035 | 58.6% | sinusitis | 4.5 | drug |
epinephrine — | 109.279 | 64.4% | sinusitis | 8.6 | drug |
endosseous dental implant — | 2.968.001 | 99.4% | — | — | device |
endosseous — | 3.346.417 | 99.4% | — | — | device |
electrode 922st 2" x 2" square 4 pk stimcare carbon cl — | 4.790.810 | 0.0% | — | — | device |
electrode — | 391.326 | 52.5% | — | — | device |
dupilumab — | 438.499 | 11.1% | Atopische dermatitis | 512.8 | drug |
duloxetine hydrochloride — | 184.178 | 61.5% | ontwenningssyndroom | 11.7 | drug |
duloxetine — | 184.186 | 61.5% | ontwenningssyndroom | 11.7 | drug |
diphenhydramine hydrochloride — | 169.045 | 70.1% | infuusgerelateerde reactie | 22.8 | drug |
diphenhydramine — | 195.250 | 68.0% | infuusgerelateerde reactie | 20.0 | drug |
dimethyl fumarate — | 122.025 | 33.2% | roodheid | 39.7 | drug |
diclofenac sodium — | 153.661 | 60.5% | anti-cyclisch citrulline peptide antistof positief | 582.5 | drug |
diclofenac — | 162.477 | 59.7% | anti-cyclisch citrulline peptide antistof positief | 586.8 | drug |
diazepam — | 119.417 | 81.0% | medicijnmisbruik | 17.2 | drug |
dextrose monohydrate — | 110.136 | 75.1% | peritonitis | 16.8 | drug |
dextrose — | 184.033 | 80.0% | Hypokaliëmie | 6.8 | drug |
dexamethasone 1.5 mg — | 286.480 | 84.5% | multipel myeloom | 42.3 | drug |
dexamethasone — | 303.290 | 84.2% | multipel myeloom | 40.7 | drug |
device — | 1.436.117 | 25.2% | — | — | device |
dental implant — | 3.208.206 | 99.3% | — | — | device |
denosumab — | 198.114 | 53.8% | kaaknecrose | 57.0 | drug |
defibrillator, automatic implantable cardioverter — | 117.596 | 68.4% | — | — | device |
defibrillator — | 751.871 | 40.1% | — | — | device |
cyclosporine — | 112.236 | 66.1% | Graft-versus-hostziekte | 58.0 | drug |
cyclophosphamide injection, solution — | 172.252 | 96.2% | koortsige neutropenie | 36.3 | drug |
cyclophosphamide for injection — | 172.253 | 96.2% | koortsige neutropenie | 36.3 | drug |
cyclophosphamide — | 172.254 | 96.2% | koortsige neutropenie | 36.3 | drug |
crutch,quick-fit,4' 7"-6' 7",walmart — | 437.238 | 0.0% | — | — | device |
continuous glucose monitoring system — | 121.156 | 14.6% | — | — | device |
continuous glucose monitoring — | 121.201 | 14.6% | — | — | device |
continuous glucose monitor — | 2.326.320 | 1.3% | — | — | device |
clozapine — | 123.200 | 94.7% | Afwijkend differentiatie-onderzoek witte bloedcellen | 1445.8 | drug |
clopidogrel bisulfate — | 99.959 | 86.6% | zwarte, teerachtige ontlasting | 15.8 | drug |
clopidogrel — | 208.698 | 81.8% | Acuut hartinfarct | 12.5 | drug |
clonazepam — | 157.182 | 68.1% | voltooide zelfmoord | 8.5 | drug |
citalopram hydrobromide — | 105.394 | 82.2% | voltooide zelfmoord | 10.6 | drug |
citalopram — | 134.738 | 77.1% | voltooide zelfmoord | 8.6 | drug |
ciprofloxacin hydrochloride — | 95.796 | 83.3% | Peespijn | 80.9 | drug |
ciprofloxacin — | 95.822 | 83.3% | Peespijn | 80.9 | drug |
cetirizine hydrochloride — | 162.357 | 54.7% | anti-cyclisch citrulline peptide antistof positief | 458.0 | drug |
cetirizine — | 169.947 | 54.8% | pemphigus | 296.5 | drug |
certolizumab pegol — | 114.573 | 64.7% | anti-cyclisch citrulline peptide antistof positief | 774.8 | drug |
celecoxib — | 129.432 | 70.3% | psoriatische artropathie | 16.7 | drug |
catheter,foley,100%silicone,16fr,10ml,lf — | 250.314 | 0.0% | — | — | device |
catheter — | 490.331 | 27.6% | — | — | device |
carvedilol — | 135.202 | 69.2% | hartfalen met longoedeem | 9.2 | drug |
carboplatin — | 122.601 | 95.2% | onderdrukking van beenmergactiviteit | 21.4 | drug |
calcium — | 592.039 | 68.4% | diabetes type 2 | 25.8 | drug |
bupropion hydrochloride — | 107.988 | 48.8% | suïcidale gedachten | 6.0 | drug |
bupropion — | 149.152 | 54.9% | voltooide zelfmoord | 10.9 | drug |
buprenorphine — | 123.005 | 60.8% | onvoldoende pijnstilling | 96.6 | drug |
budesonide — | 160.438 | 60.5% | astma | 25.0 | drug |
blood glucose monitoring system — | 111.358 | 6.0% | — | — | device |
blood glucose monitoring — | 204.724 | 8.2% | — | — | device |
blood glucose — | 243.514 | 9.0% | — | — | device |
bisoprolol fumarate — | 132.846 | 96.6% | hyperkaliëmie | 11.2 | drug |
bevacizumab — | 126.289 | 88.8% | Eiwit in urine | 33.4 | drug |
bed — | 100.747 | 3.5% | — | — | device |
bd needle 26g 5/8" 1ml sub-q - product#309597 — | 11.625.940 | 100.0% | — | — | device |
bd e-z scrub¿ impregnated preoperative scrub brushes (with 4% chg) - canada — | 14.567.345 | 0.0% | — | — | device |
automated insulin dosing, threshold suspend — | 168.919 | 11.2% | — | — | device |
automated insulin dosing device system, single hormonal control — | 444.343 | 12.2% | — | — | device |
atorvastatin calcium — | 243.012 | 65.1% | diabetes type 2 | 45.0 | drug |
atenolol — | 133.343 | 70.3% | Bradycardie | 6.9 | drug |
aspirin 81 mg — | 502.540 | 71.7% | GI bloeding | 7.1 | drug |
aspirin 325 mg — | 500.597 | 71.8% | GI bloeding | 7.1 | drug |
aspirin — | 552.493 | 69.8% | GI bloeding | 7.4 | drug |
artificial pancreas device system, threshold suspend — | 197.524 | 22.8% | — | — | device |
artificial pancreas device system, single hormonal control — | 418.464 | 17.3% | — | — | device |
aripiprazole — | 123.730 | 65.0% | gokverslaving | 549.0 | drug |
apremilast — | 144.030 | 23.2% | psoriatische artropathie | 38.3 | drug |
amoxicillin — | 99.955 | 79.4% | ernstige nierziekte | 18.2 | drug |
amlodipine besylate — | 166.351 | 69.5% | chronische nierziekte | 5.8 | drug |
amlodipine — | 431.535 | 74.3% | chronische nierziekte | 5.8 | drug |
ambrisentan — | 123.381 | 64.8% | Pulmonale arteriële hypertensie | 51.4 | drug |
alternate controller enabled insulin infusion pump — | 523.532 | 12.7% | — | — | device |
alternate controller enabled infusion pump — | 589.445 | 9.8% | — | — | device |
alprazolam — | 202.857 | 70.7% | medicijnmisbruik | 16.4 | drug |
allopurinol — | 153.758 | 82.1% | jicht | 19.6 | drug |
alendronate sodium — | 100.127 | 78.6% | anti-cyclisch citrulline peptide antistof positief | 710.9 | drug |
albuterol sulfate — | 289.568 | 56.8% | Probleem met afgiftesysteem van hulpmiddel | 58.0 | drug |
albuterol — | 291.471 | 56.8% | Probleem met afgiftesysteem van hulpmiddel | 57.7 | drug |
adapalene — | 181.371 | 0.7% | Chemische brandwond van de huid | 282.9 | drug |
adalimumab — | 715.350 | 51.4% | gecontra-indiceerd product toegediend | 19.6 | drug |
acyclovir — | 112.882 | 72.5% | multipel myeloom | 13.3 | drug |
acetaminophen, guaifenesin, and phenylephrine hydrochloride — | 156.094 | 59.3% | infuusgerelateerde reactie | 10.8 | drug |
acetaminophen tablet extended release — | 246.995 | 87.3% | infuusgerelateerde reactie | 17.6 | drug |
acetaminophen 500mg — | 247.585 | 87.3% | infuusgerelateerde reactie | 17.6 | drug |
acetaminophen — | 668.254 | 71.2% | afhankelijkheid | 21.0 | drug |
accessories — | 150.638 | 23.4% | — | — | device |
abatacept — | 135.351 | 60.5% | anti-cyclisch citrulline peptide antistof positief | 562.7 | drug |
96" adult exp,gse,par wye,(2)bv,lg.mask,3lf bag,3lf bag,10'x.050" mm gsl, — | 18.708.026 | 0.0% | — | — | device |
3-way "y" connector — | 25.000.667 | 0.4% | — | — | device |
22 ga iv catheter system with "y" adapter — | 25.000.548 | 0.1% | — | — | device |
1.6mm "y" plate, locking — | 25.000.438 | 0.0% | — | — | device |
(to deliver) avobenzone 3%, homosalate 5%, octisalate 10%, octocrylene 5% — | 4.919.809 | 65.6% | medicijninteractie | 3.9 | drug |
(to deliver) avobenzone 3%, homosalate 10%,octisalate 5%, octocrylene 5% — | 5.064.083 | 63.8% | medicijninteractie | 3.7 | drug |
(to deliver) avobenzone 2%, homosalate 8%, octisalate 4.5%, octocrylene 7% — | 5.091.938 | 65.8% | medicijninteractie | 3.9 | drug |
"z" plate — | 1.994.896 | 5.2% | — | — | device |
"y" o2 outlet — | 25.000.438 | 0.0% | — | — | device |
"y" extension set — | 25.000.488 | 0.0% | — | — | device |
"y" endotracheal tube adapter closed suction system — | 25.000.438 | 0.0% | — | — | device |
"quick fit sling" for patient lift. — | 196.964 | 0.0% | — | — | device |
"j" style bone marrow biopsy needle — | 154.080 | 0.0% | — | — | device |
"j" guidewire — | 278.717 | 15.1% | — | — | device |
.018 "guidewire" with floppy platinum tip — | 130.383 | 0.0% | — | — | device |
.014 floppy "j" wire — | 686.635 | 15.4% | — | — | device |